Find Sites

Wastewater surveillance analyses sewage samples to identify biological or chemical signals produced by communities. Because wastewater combines material from many households and buildings, testing can provide a population-level view of changing health conditions without examining every individual. Public health agencies, laboratories, wastewater utilities, universities, and healthcare organisations are increasingly using this approach to complement clinical testing and conventional disease-reporting systems.

A recent study by Markntel Advisor highlights that the global wastewater surveillance landscape was valued at USD 0.86 billion in 2025. It is projected to grow from USD 0.92 billion in 2026 to USD 1.34 billion by 2032, registering a CAGR of 6.47% during 2026–2032. Expansion reflects infectious-disease monitoring, laboratory development, genomic analysis, public-health preparedness, and wider integration of wastewater information into surveillance programmes.

Community Samples Provide Early Health Signals

People infected with certain pathogens may release biological material through bodily waste, even when symptoms are mild or absent. Wastewater samples collected from treatment plants, sewer networks, or selected facilities can therefore indicate whether a pathogen is circulating within the contributing population.

The CDC’s wastewater monitoring programme uses this approach to support infectious-disease detection and public-health response. Unlike clinical reporting, wastewater monitoring does not depend entirely on people visiting healthcare providers or receiving diagnostic tests, making it a useful complement to other surveillance information.

Surveillance Extends Beyond a Single Disease

Wastewater testing became widely recognised during the COVID-19 pandemic, but environmental surveillance has a longer history. Public-health programmes have used sewage monitoring to track poliovirus and assess whether transmission may be occurring within communities.

Current programmes are expanding toward respiratory viruses, antimicrobial resistance, gastrointestinal pathogens, and other emerging health threats. The World Health Organization’s global wastewater assessment identifies strong international interest in wastewater and environmental surveillance as a complement to established public-health systems.

Laboratory Technology Improves Detection

Wastewater contains complex mixtures of biological material, chemicals, solids, and industrial contaminants. Laboratories must concentrate the target material, remove substances that interfere with testing, and use validated methods to produce dependable results.

Polymerase chain reaction testing can identify genetic material from selected pathogens, while genomic sequencing can help distinguish variants or strains. Automated sampling equipment, improved laboratory workflows, and digital reporting systems are making surveillance programmes more consistent. However, comparisons across locations still require standardised sampling, processing, quality control, and data interpretation.

Public-Health Decisions Require Additional Context

A rising wastewater signal can indicate increasing community transmission, but it cannot determine exactly how many people are infected. Results may be influenced by rainfall, industrial discharge, population movement, sewer design, sampling frequency, and differences in how pathogens are released.

Public-health teams must therefore interpret wastewater information alongside clinical cases, hospital admissions, laboratory results, vaccination data, and other indicators. The ECDC integration framework emphasises incorporating wastewater-based surveillance into wider infectious-disease monitoring and decision-making rather than treating it as an isolated dataset.

Targeted Sampling Supports Local Monitoring

Wastewater surveillance can operate at several geographical levels. Samples from a major treatment plant may represent a large city, while neighbourhood sewer sites can provide more localised information. Sampling may also be conducted at airports, universities, hospitals, prisons, care facilities, or other locations with clearly defined populations.

More targeted monitoring can help agencies investigate specific risks, but smaller sampling areas may also produce less stable signals. Locations with highly mobile populations, such as tourist areas, require additional care because the number and composition of contributing individuals can change considerably over time.

Data Systems Improve Timely Reporting

Laboratory results become more valuable when they can be transferred, analysed, and communicated quickly. Digital dashboards help public-health teams compare locations, identify trends, and share findings with decision-makers.

Automated data submissions can reduce delays and support more consistent national reporting. The CDC includes wastewater information among the core public-health data sources being integrated to improve trend detection, resource allocation, and responses to emerging threats.

Governance and Sustainability Remain Important

Wastewater surveillance programmes require stable funding, laboratory capacity, trained staff, access to sampling locations, and cooperation between health agencies and utility operators. They must also establish clear rules for data ownership, public communication, ethical use, and long-term programme evaluation.

Although community-level wastewater data is generally less personally identifiable than individual medical records, highly localised sampling may raise concerns about stigma or inappropriate interpretation. Governance frameworks must ensure that results are used proportionately and communicated without unfairly labelling particular communities.

Integrated Surveillance Shapes Future Adoption

Global wastewater surveillance is becoming increasingly connected with pandemic preparedness, infectious-disease monitoring, genomic analysis, and public-health data integration. Its main value lies in providing an additional community-level signal that can identify changing trends before every infection appears through clinical reporting.

Future development will depend on standardised testing, sustainable funding, reliable digital systems, and clear interpretation frameworks. When combined with clinical and epidemiological information, wastewater surveillance can strengthen early warning capabilities and support more informed public-health decisions.